...
search icon
mtsr-img

Metsera, Inc. Common Stock, Common Stock

MTSR

NSQ

$30.141

-$4.44

(-12.84%)

1D
Industry: Biotechnology Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$3.01B
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
579.59K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$12.3 L
$37.99 H
$30.141

About Metsera, Inc. Common Stock, Common Stock

Metsera, Inc., a clinical-stage biotechnology company, develops injectable and oral nutrient stimulated hormone analog peptides to treat obesity, overweight, and related diseases. It develops MET-097i and MET-233i for the treatment of obesity and overweight; MET-233i/MET-097i; and MET-002, MET-224o, MET-067i, and MET-034i to treat disorders, such as diabetes and obesity, as well as MET-815i to reduce weight or prevents weight gain. The company was incorporated in 2022 and is based in New York, New York. more

Industry: BiotechnologySector: Health Care

Returns

Time FrameMTSRSectorS&P500
1-Week Return20.61%2.78%1.81%
1-Month Return31.08%0.63%3.55%
3-Month Return34.13%-5.39%8.02%
6-Month Return92.11%-2.98%-0.13%

Financials

Dec '22Dec '23Dec '24
Total Revenue---[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Cost of Revenue---[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Gross Profit---[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Gross Margin---[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Operating Expenses667.00K43.67M224.83M[{"date":"2022-12-31","value":0.3,"profit":true},{"date":"2023-12-31","value":19.42,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Operating Income(667.00K)(43.67M)(224.83M)[{"date":"2022-12-31","value":-66700000,"profit":false},{"date":"2023-12-31","value":-4366900000,"profit":false},{"date":"2024-12-31","value":-22483300000,"profit":false}]
Total Non-Operating Income/Expense-(1.62M)12.33M[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":-13.13,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]
Pre-Tax Income(813.00K)(47.21M)(218.47M)[{"date":"2022-12-31","value":-81300000,"profit":false},{"date":"2023-12-31","value":-4720600000,"profit":false},{"date":"2024-12-31","value":-21846500000,"profit":false}]
Income Taxes--(9.34M)[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":-933800000,"profit":false}]
Income After Taxes--(209.13M)[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":-20912700000,"profit":false}]
Income From Continuous Operations-(47.21M)(209.13M)[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":-4720600000,"profit":false},{"date":"2024-12-31","value":-20912700000,"profit":false}]
Income From Discontinued Operations---[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income(813.00K)(47.21M)(209.13M)[{"date":"2022-12-31","value":-81300000,"profit":false},{"date":"2023-12-31","value":-4720600000,"profit":false},{"date":"2024-12-31","value":-20912700000,"profit":false}]
EPS (Diluted)--(0.50)[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":-50.33,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

MTSR
Cash Ratio 6.48
Current Ratio 6.55

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

MTSR
ROA (LTM) 0.00%
ROE (LTM) 0.00%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

MTSR
Debt Ratio Lower is generally better. Negative is bad. 0.27
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.73

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

MTSR
Trailing PE NM
Forward PE NM
P/S (TTM) 0.00
P/B 0.00
Price/FCF NM
EV/R 0.00
EV/Ebitda NM

FAQs

What is Metsera, Inc. Common Stock share price today?

Metsera, Inc. Common Stock (MTSR) share price today is $30.141

Can Indians buy Metsera, Inc. Common Stock shares?

Yes, Indians can buy shares of Metsera, Inc. Common Stock (MTSR) on Vested. To buy Metsera, Inc. Common Stock from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in MTSR stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Metsera, Inc. Common Stock be purchased?

Yes, you can purchase fractional shares of Metsera, Inc. Common Stock (MTSR) via the Vested app. You can start investing in Metsera, Inc. Common Stock (MTSR) with a minimum investment of $1.

How to invest in Metsera, Inc. Common Stock shares from India?

You can invest in shares of Metsera, Inc. Common Stock (MTSR) via Vested in three simple steps:

  • Click on Sign Up or Invest in MTSR stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Metsera, Inc. Common Stock shares
What is Metsera, Inc. Common Stock 52-week high and low stock price?

The 52-week high price of Metsera, Inc. Common Stock (MTSR) is $37.99. The 52-week low price of Metsera, Inc. Common Stock (MTSR) is $12.3.

What is Metsera, Inc. Common Stock price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Metsera, Inc. Common Stock (MTSR) is 0.00

What is the Market Cap of Metsera, Inc. Common Stock?

The market capitalization of Metsera, Inc. Common Stock (MTSR) is $3.01B

What is Metsera, Inc. Common Stock’s stock symbol?

The stock symbol (or ticker) of Metsera, Inc. Common Stock is MTSR

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top